Chinese companies are filing a lot more IPR petitions at the PTAB than they used to. https://t.co/uLR5xDbsk6
Leading Chinese companies are beginning to make much greater use of the inter partes review process in the US. https://t.co/uLR5xDbsk6
Beijing-based medical device manufacturer BMC Medical this week touted a recent inter partes review (IPR) decision knocking out a patent that competitor ResMed has used to sue the Chinese company in the US. The two companies make masks and humidifiers designed to treat sleep-disordered breathing and other respiratory problems, and have been fighting over patents since at least 2013 in...
Since post-issuance proceedings were overhauled at the USPTO in 2012, following the passing of the America Invents Act, there has been much analysis and – in some quarters – outcry over the effect that they have had on patent rights in the US. The initial high level of institutions and subsequent claim invalidation rates in inter partes reviews have, of course, become the subject...
Korea will need more than litigation risk reduction to put its IP rights balance firmly in the black
The License On Transfer (LOT) Network announced last week that it has welcomed Hyundai Motor and its affiliate Kia Motors as its first new members in 2016. As well as being the second and third automotive OEM companies to sign up to the alliance since Ford and Mazda joined in February and March respectively last year, Hyundai and Kia are also LOT’s first Korean members. The LOT...
IAM Patent 1000
The definitive guide to leading patent lawyers, attorneys and firms in over 40 jurisdictions, with a special section on expert witnesses in the United States.Visit site